₨180.00
No
Dexibuprofen
Pain & Inflammation
Dexibuprofen, a racemic ibuprofen belongs to a family of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). Like other NSAIDs, dexibuprofen acts by inhibiting prostaglandin synthesis. It reduces pain, inflammation and fever and reversibly inhibits ADP and collagen stimulated platelet aggregation.
The dosage should be adjusted according to the severity of the disorder and the complaints of the patient. The maximum single dose is 400mg, the maximum daily dose is 1200mg dexibuprofen. Osteoarthritis : The recommended dose is 600mg to 900mg dexibuprofen daily, divided in up to three single doses. The dose may be increased up to 1200mg dexibuprofen per day in patients with acute conditions or exacerbations. Dysmenorrhea : The recommended dose is 600mg to 900mg dexibuprofen daily, divided in up to three single doses. Children : Not recommended. Always consult with your doctor or pharmacist for dose adjustments.
Common : Dyspepsia, diarrhea, nausea, vomiting, abdominal pain, rash, fatigue or drowsiness, headache, dizziness, vertigo, edema and hypertension.Uncommon : Gastrointestinal ulcers and bleeding, ulcerative stomatitis, gastritis, malaena, urticaria, pruritus, purpura (including allergic purpura), angioedema, rhinitis, bronchospasm, insomnia, anxiety, restlessness, visual disturbances and tinnitus.Rare : Gastrointestinal perforation, flatulence, constipation, esophagitis, esophageal strictures, exacerbation of diverticular disease, unspecific hemorrhagic colitis, ulcerative colitis, Crohn’s disease, anaphylactic reactions, psychotic reactions, depression, irritability, disorientation, confusion, agitation, reversible toxic amblyopia, impaired hearing, abnormal liver function, hepatitis, jaundice, blood disorders including thrombocytopenia, leucopenia, granulocytopenia, pancytopenia, agranulocytosis, aplastic anemia or hemolytic anemia.
Anti-coagulants, such as warfarin , Methotrexate , Lithium , NSAIDs and salicylates , Diuretics , sulphonylurea , Zidovudine (Azidothymidine) , Pemetrexed , Alcohol , Cyclosporine, tacrolimus, sirolimus and aminoglycoside antibiotic , Corticosteroids , Digoxin , Phenytoin, phenobarbital and rifampicin , Thrombolytics, ticlopidine and antiplatelet agents.
Dexibuprofen is indicated for: – Symptomatic treatment for the relief of pain and inflammation associated with osteoarthritis. – Acute symptomatic treatment of pain during menstrual bleeding (primary dysmenorrhea). – Symptomatic treatment of mild to moderate pain, such as muscular skeletal pain or dental pain. – It may be used as an antipyretic to reduce fever.
Dexibuprofen is contraindicated in patients: – Previously sensitive to dexibuprofen, to any other NSAID, or to any of the excipients of the product. – In whom substances with a similar action (e.g., aspirin or other NSAIDs) precipitate attacks of asthma, bronchospasm, acute rhinitis, or cause nasal polyps, urticaria or angioneurotic edema. – With a history of gastrointestinal bleeding or perforation, related to previous NSAID therapy. – With active, or a history of recurrent peptic ulcer/hemorrhage (two or more distinct episodes of proven ulceration or bleeding). – With cerebrovascular bleeding or other active bleedings. – With active Crohn’s disease or active ulcerative colitis. – With severe heart failure. – With severe renal dysfunction (GFR < 30 ml/min). – With severely impaired hepatic function. – From the beginning of 6th month of pregnancy
The use of dexibuprofen with concomitant NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided. Care is recommended in conditions that predispose patients to the gastrointestinal adverse effects of NSAIDs. These patients should be closely monitored for digestive disturbances, especially gastrointestinal bleeding, perforation & ulceration.
Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and edema have been reported in association with NSAID therapy. Patients with uncontrolled hypertension, congestive heart failure, established ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with dexibuprofen after careful consideration.
If used in the patients with renal or hepatic disease, the dose of dexibuprofen should be kept as low as possible and renal function should be regularly monitored.
Dexibuprofen should only be given with care to patients with systemic lupus erythematosus and mixed connective tissue disease because such patients may be predisposed to NSAID-induced renal and CNS side effects, including aseptic meningitis.
Always consult your physician before using any medicine.
Store this medicine at room temperature, away from direct light and heat.